. These naturally occurring and highly potent neurotoxins are produced by microscopic algae (e.g., the dinoflagellate Alexandrium spp.) along the California coast, which can accumulate in filter-feeding molluscan shellfish such as mussels, clams, oysters, and scallops.
To protect the public from PSP, the California Department of Public Health (CDPH) initiated a PSP monitoring program in response to a large-scale outbreak in 1927. The current CDPH Marine Biotoxin Monitoring Program (MBMP) consists of program participants from county health departments and other local, state, federal, tribal, and academic organizations, shellfish aquaculture companies, and a growing number of citizen volunteers, who collect shellfish and phytoplankton samples at numerous points along the California coastline. Shellfish samples, predominantly sea mussels (Mytilus californianus), are immediately frozen, and then shipped to the CDPH laboratory campus in Richmond for toxin testing. This monitoring data is used to establish commercial shellfish harvesting closures and to issue health advisories and quarantines for recreational harvesting areas. A c c e p t e d M a n u s c r i p t
The PSP test method currently used at the CDPH Microbial Diseases Laboratory (MDL) is the AOAC-approved Mouse Bioassay (MBA), an in vivo test that has until recently been the only approved method under the National Shellfish Sanitation Program (NSSP). In the MBA method, 19-21 gram mice are injected with 1 mL of an acid extract of the shellfish and the time of death (i.e. from inoculation to last gasping breath) is recorded. CDPH-MDL has previously reported on the comparison of a number of different promising screening assays for the PSP toxins (Inami et al. 2004 ).
This work led to the adoption of a commercially available qualitative lateral flow immunoassay (Scotia ® Rapid Testing Systems Ltd.) (Jellett et al. 2002) for screening incoming shellfish samples. This qualitative test was approved by the Interstate Shellfish Sanitation Conference (ISSC 2013) and incorporated into the NSSP as a screening tool in 2005. Although use of this screening method has significantly reduced the number of animals sacrificed (Oshiro et al. 2006) , it is still necessary to have positive samples tested by MBA for quantitation, which is needed for regulatory decision-making.
The receptor binding assay (RBA) does not use live animals and is based on the competitive binding for a finite number of receptor sites in a rat membrane tissue homogenate between PSP toxins in the shellfish tissue and added radiolabeled STX ( 3 H-STX), (Hartshorne & Cattrall, 1984) . Since all STX congeners bind to site 1 of voltagegated sodium channels and binding affinity is proportional to potency, this makes the RBA a very specific method for the detection of PSP toxins (Lipkind & Fozzard 1994) .
One of several advantages of the RBA over the MBA is its lower detection limit (60 -100 μg STX equiv. kg A c c e p t e d M a n u s c r i p t resources and alert the public. RBA for PSP has undergone single and multi-lab validation studies, leading to acceptance by AOAC as an official method of analysis (OMA # 2011.27) . In 2013, the RBA was approved by the ISSC (ISSC, 2013) as an Approved Limited Use Method, which is defined as a permanent method accepted for use in the NSSP but of limited scope due to a lack of data for some applications (NSSP Guide for the Control of Molluscan Shellfish, 2017). The ISSC limited the RBA to the testing of mussel and clam tissue, which were the shellfish matrices most thoroughly evaluated, with other matrices to be incorporated pending approval of matrix extension study results. Currently laboratory testing is underway at CDPH to validate the RBA for use with oyster tissue. An alternative technique for the detection of PSP toxins is a HPLC method (Lawrence et al. 2005; van de Riet et al. 2009 ), which has also been accepted by the ISSC and U.S. Food and Drug Administration (USFDA) as an Approved Method for unlimited use within the NSSP.
Our effort has been to eliminate the reliance on live animals while improving our analytical capacity with a method that is more sensitive and allows for some automation, thereby increasing sample throughput. We have been exploring the RBA as an alternate test method for the MBA (Ruberu et al. 2003 and Ruberu et al. 2012 ) in joint studies with the Center for Coastal Environmental Health and Biomolecular Research, National Oceanographic and Atmospheric Administration (NOAA) and the USFDA. Our initial work demonstrated PSP toxin concentrations measured by the RBA to be generally higher than those measured by the MBA (Ruberu et al. 2003) .
This difference has been attributed to salt/shellfish tissue matrix effects (LeDoux & Hall 2000 , Schantz et al. 1958 , to the presence of metals such as zinc and manganese (Turner et al. 2011) , or to the difference in response to the various PSP toxin congeners between the in vitro RBA and in vivo MBA (Usup et al. 2004 A c c e p t e d M a n u s c r i p t focused on testing the accuracy, recovery, ruggedness, and comparability of the RBA under regulatory conditions. We began with a single laboratory spiking study, looking at shellfish extracts that were filtered through a 0.45 micron membrane filter and those that were unfiltered, spiked with known STX concentrations and analysed for recovery. Furthermore, with technical support from the USFDA Center for Food Safety and Applied Nutrition, a multi-laboratory spiking study was designed to compare variability among laboratories for the recovery of STX spiked shellfish extract by both RBA and MBA. In addition, a thorough comparison between RBA and MBA was conducted by analysing 295 naturally-contaminated shellfish samples collected from 92 sites along the coast of California. Finally, we have provided suggestions for optimizing the RBA in a regulatory laboratory environment. • USFDA STX reference standard, STX dihydrochloride at 268.8 μM (100 ug mL -1 ) (Lot #088, 100 μg mL -1 in 20% ethanol-water at pH 3.5) -USFDA, Office of Seafood (Laurel, MD).
Materials and methods

Chemicals and Reagents
• Rat Membrane Homogenate -The rat membrane preparation containing the sodium channel receptors was composed of 20 brains from 6-week old male Holtsman rats (Harlan Bioproducts, Indianapolis, IN) and prepared according to the methodology of Doucette et al. (1997) . This preparation was divided into 2 mL aliquots and frozen at -70° C. A single aliquot was thawed for each RBA plate and diluted with cold buffer (see RBA Buffer below) to yield a protein concentration of 1 mg mL -1 (dilution determined by conducting a protein assay). A c c e p t e d M a n u s c r i p t
• RBA Buffer -For the multi-laboratory study, reagents, standards, and dilutions were prepared in 100 mM MOPS/100 mM choline Cl buffer at pH 7.4. To prepare the MOPS buffer, 20.9 g of MOPS (3-morpholinopropanesulfonic acid), 13.96 g of choline chloride was dissolved in 900 mL of water, pH adjusted to 7.4 with NaOH and the final volume brought to 1 L. For all other studies, 75 mM HEPES/140 mM NaCl buffer at pH 7.5 was used. To prepare the HEPES buffer, 17.9 g of HEPES and 8.2 g of NaCl was dissolved in 900 mL of water, pH adjusted to 7.5 with NaOH and the final volume brought to 1 L.
Instrumentation
Scintillation counting was performed on a PerkinElmer TopCount plate reader with 12 detectors for all samples analysed at RBA-Lab 1, and on a PerkinElmer TopCount plate reader with 2 detectors for all samples analyzed at RBA-Lab 2. MicroScint-20 cocktail (PerkinElmer) was used as the scintillant for all RBA work.
Shellfish tissue extraction
Tissue homogenates were extracted using the AOAC mouse bioassay extraction protocol (AOAC, 1999) for the MBA, RBA and for screening using the Scotia Rapid Test (SRT) in the laboratory. For the AOAC extraction (SRT-AOAC), 100 g of shellfish tissue homogenate was combined with 100 mL of 0.1 M hydrochloric acid, pH adjusted between 1 -4, boiled for 5 min, cooled, and final volume made to 200 mL.
The mixture was centrifuged for 5 min at 3000 x g and the supernatant analysed.
When shellfish samples were screened in the field using the SRT, a rapid extraction method (SRT-RE) provided by the manufacturer, consisting of rubbing alcohol and vinegar, was used. For the rapid extraction 10 mL of shellfish tissue homogenate was combined with 10 mL of rapid extraction liquid (2.5:1 solution of 70% isopropyl alcohol and 5% acetic acid), shaken thoroughly to mix the contents and the A c c e p t e d M a n u s c r i p t homogenate drained through a paper paint filter. The filtered extract was used for analysis.
RBA-Lab 1 Protocol
The methodology of Doucette (Doucette et al. 1997) as modified by Ruberu (Ruberu et al. 2003) M STX standard, independently made, was used as a daily QC check. All pipetting was carried out using an 8-channel pipet. To achieve equilibrium binding, the plate was incubated for 1 hour at 4º C, then filtered using a MultiScreen vacuum manifold system (EMD Millipore, part # MSVMHTS00), and rinsed with 200 μL of 4º C buffer to remove unbound toxin. To each well, 50 μL of the scintillant (MicroScint) was added, and the top of the plate sealed with tape. The prepared plate was placed inside the TopCount scintillation counter for 30 minutes. This allowed the scintillant to dark-adapt and the contents to mix, prior to counting the receptor-bound A c c e p t e d M a n u s c r i p t Criteria that must be met for assay acceptance are as follows: (1) the slope of the standard curve must be between 0.8 to 1.2, (2) the counts per minute (CPM) relative standard deviation (RSD) for each standard must be <30%, and (3) the QC check must be +/-30% of the in-assay concentration of 3.0x10 -9 M STX. Criteria for sample acceptance and quantification are; (1) B/B0 = 0.3 to 0.7 and (2) RSD of triplicate wells for a sample CPM must be <30%.
RBA-Lab 2 Protocol
A modification of the methodology described in Van Dolah (Van Dolah et al. 2012 
MBA Protocol
The AOAC procedure was followed for sample assay by the MBA method (AOAC, 1999) .
Shellfish Extracts for the Single Laboratory Study
Sea mussels (Mytilus californianus) from Del Norte County (100 -120 μg STX equiv. 
Spiking Shellfish Extracts for the Multi Laboratory Study
Bay mussel tissue extracts free of PSP toxins (<LOD measured by RBA) collected from Agua Hedionda Lagoon in San Diego was spiked with USFDA STX reference standard to yield the final concentrations of 400, 500, 600, 700, 800, 900, 1000, 1500, 1750, and 2000 μg STX equiv. kg A c c e p t e d M a n u s c r i p t the aliquots were for the participating three laboratories while the fourth aliquot was archived. All prepared samples and blank tissue extract were held at -80° C prior to shipment. They were packed with dry ice in an insulated styrofoam container and shipped via next day courier service. Samples arrived in frozen condition at each laboratory. Aside from the coded identification number on each sample, the study was blind to participants.
Results and Discussion
Statistical Analysis of all Data
RBA samples were run in triplicate, resulting in some variability among a set of replicate wells. According to the AOAC protocol's acceptance criteria, any sample with an RSD > 30% among triplicate wells is rejected. This can be problematic, as a discarded sample must be re-assayed, resulting in a delay in obtaining critical data and increasing the operating cost of the assay. Furthermore, if the reference blank is rejected then all data from that plate will be lost, since the percent binding is determined using its CPM value (i.e. 100% binding). One of our efforts has been focused on ways to evaluate a set of triplicate data from a single plate for acceptability (Ruberu et al. 2012) . In that study we explored two types of data treatments, Grubbs' test and Student's t-test for rejecting outliers in triplicate wells, and concluded there was the possibility of compromising accuracy with either approach. After careful consideration, we chose to evaluate data presented in this study according to the AOAC protocol criteria. It should be noted that NOAA criteria are part of the AOAC method as accepted by ISSC. All statistical analyses were performed using MedCalc for Windows Windows, version 14.10.2 (MedCalc Software, Ostend, Belgium). A c c e p t e d M a n u s c r i p t Two spiking ranges were chosen; Range I samples were spiked at 400, 600, 700, 800, 1000, 2500, 5000, and 10,000 μg STX equiv. kg -1 , and Range II samples were spiked at 50,100, 200, 300, and 400 μg STX equiv. kg -1 using the USFDA STX standard. Range I concentrations are detectable by MBA while Range II concentrations fall below the MBA limit of detection, with the possible exception of the 400 μg STX equiv. kg -1 spike. Two tissue extract preparations were used, filtered and unfiltered (see experimental section). The comparison of filtered and unfiltered extracts revealed whether further purification of the sample extract improved the accuracy or precision of spike recovery. Each concentration range was analysed on three separate days to examine assay reproducibility from day-to-day and from plate-to-plate. Each concentration was run at 3-4 dilutions on each plate and the average result was used. If any of the dilutions failed the AOAC criteria with RSD >30%, that value was not used to calculate the average. A tissue blank was run on each plate and its CPM value was subtracted from the spiked sample CPM values.
Single Laboratory Spiking Study
Study Plan
Unfiltered and Filtered Samples
Data from the two spiking ranges for all three days were combined and analysed to determine if there was a significant difference in the results between the filtered and unfiltered samples (Table 1) . Although overall variability among replicates (based on RSD) for the filtered sample data were higher (average RSD 32%) compared to that of the unfiltered (average RSD 15%), a paired-comparison t-test showed no significant difference (P = 0.05) in the results between the filtered and unfiltered samples (P = 0.62). The high variability of the filtered sample data was of concern and may have affected the ability to determine if a statistically significant difference existed between data sets. The unfiltered sample data was less variable and represented one less step in tissue. This increased variability at the highest concentrations can be associated with high dilution ratios and very small volumes used in the assay.
Accuracy/Trueness
Method accuracy/trueness was determined by averaging the triplicate recoveries for all of the 12 spike concentrations (n = 42), dividing this mean by the average of the spike concentrations, and then multiplying this quotient by 100. The estimated accuracy/trueness of the RBA for unfiltered samples was 115%. An alternative approach used in the AOAC inter-laboratory validation study (Van Dolah et al. 2012) was to determine accuracy based on the recovery of the 3.0 nM QC sample data from multiple plates. To use this approach, we looked at our control chart data (Ruberu et al. 2012 ) for the QC sample. Based on the actual mean recovery of the QC sample for 66 plates run over many years, the calculated accuracy was 101%.
Recovery
The results for the triplicate unfiltered samples results were averaged for each spike concentration. Each mean value was then subtracted from the corresponding spike concentration. A one-way analysis of variance (ANOVA) determined that there was no significant difference (P>0.05; P = 0.66) in spike recovery over the range of concentrations used (50 -10,000 μg STX equiv. kg -1 ). Recoveries (Table 1) A c c e p t e d M a n u s c r i p t greater than 100% for all spike concentrations, ranging from 106% to 189%, except for the 2500 μg STX equiv. kg -1 which was 93%. There was no pattern of increasing or decreasing recovery with increasing spike concentration. The AOAC single laboratory validation study (Van Dolah et al. 2009 ) reported recoveries of 115 to 129% for spiked mussel tissue, while recoveries have shown to vary from 82% to 131% in different congeners of toxins (Usup et al. 2004 ).
Repeatability
Method repeatability was evaluated by comparing data from the unfiltered samples in the spiking study over the three different days that plates were run. A one-way ANOVA demonstrated that there was no significant difference (P > 0.05; P = 0.94) in spike recoveries among the three days. It should be noted that the reagents used on the different days were from the same stock solutions and standards.
Precision: The precision of the RBA was evaluated using the RSD for the triplicates of each of the twelve spike concentrations used in the unfiltered samples. RSDs ranged from 4% to 25% (Table 1) , with an average of 15%. There was no pattern of increasing or decreasing precision relative to the spike concentration. The 2012 collaborative study (Van Dolah et al. 2012 ) had found the average RSD for routine users of the RBA to be 17%, which is consistent with the present study.
Comparison of RBA and MBA in Testing Naturally-Contaminated Shellfish Tissue
Sampling Procedure
The CDPH MBMP generates weekly mussel samples and oyster samples as needed from commercial shellfish growing areas, with coastal recreational sites sampled by program participants collecting samples consisting mostly of sea mussels and occasional bay mussels. On average over 1200 samples per year are collected statewide for PSP toxin analysis. Mussels are efficient at filtering out the toxin-containing 
Correlation between RBA and MBA
A total of 295 samples were used for this study, 190 of which contained detectable PSP toxins by both the MBA and RBA. STX equivalents in these naturally-contaminated samples ranged from 320 to 13,000 μg STX equiv. kg (Figure 3 ). This is consistent with our previous work (Ruberu et al. 2003) and deemed acceptable considering the inherent variability or uncertainty of each method (~ +/-20%) (Doucette et al. 1997 ).
Conversely, rather than indicating a positive bias in the RBA, the slope of the Deming Regression could be the result of a negative bias in the MBA. For the sake of simplifying this discussion we will refer to the RBA bias relative to the MBA rather than cite the converse relationship each time, keeping in mind that the latter is just as likely. ). Given the linear response of the RBA at concentrations well below this range it is more likely that the error resides with the MBA. The source of increased variability at higher concentrations also could not be determined. Possible explanations include the lack of precision in determining death times in the MBA ("last gasping breath") and error associated with high dilution ratios and very small volumes in the RBA. Regardless, the RBA performed reliably in terms of accuracy, precision, and linearity in the critical range about the 800 μg STX equiv. kg 
Multi-Laboratory Spiking Study
Study Plan
The disparity observed in the paired RBA-MBA results was suspected to be the result of matrix effects and other sources of error within the MBA as discussed previously, however there was no direct evidence that this was the case. Therefore, a study was designed to evaluate the recovery of shellfish extracts spiked with STX at several 
Data Comparison
Spike recovery data from the three labs are presented in Table 2 , respectively).
Statistical Evaluation of Data
There was a general pattern of increasing variances of the RBA triplicate spike recovery data with increasing spike concentration. This pattern was most pronounced at the two highest concentrations. One assumption of parametric statistics is that the variance is independent of the mean, which does not appear to be the case with the RBA spike recovery data. Therefore, the raw spike recovery data for all three labs was logtransformed, which corrected the inequality of error variances according to the Levene's test (P>0.05; P = 0.17). The log-transformed data was analysed by one-way ANOVA (MedCalc, version 14.10.2), which determined that there was a significant difference between laboratories for spike recoveries (P<0.05). Post Hoc pairwise comparisons using the Student-Neuman-Keuls method showed no significant difference between the RBA-Lab 1 and RBA-Lab 2 data sets (P>0.05) but showed a significant difference between the MBA-Lab 1 and each set of RBA data as well as with the expected values (i.e., spike concentrations) (P<0.05).
The results of this inter-laboratory study clearly demonstrate the RBA to be more accurate than the MBA for recovery of STX-spiked mussel tissue extract. The , respectively while Le Doux et al. (2000) determined in an inter-laboratory study of the MBA that this method underestimated STX concentration by as much as 60%, which was attributed to matrix or 'salt' effects described by others (Schantz et al., 1958; McFarren 1959; Ares et al. 1982; Park et al. 1986 ). ). Therefore, a determination of the RBA detection limit in our laboratory is of little importance relative to the working range for routine monitoring.
Limit of Detection (LOD) and Limit of Quantification (LOQ)
Using
Optimizing RBA for Regulatory Use
Screening Plates
Under regulatory conditions, state laboratories test thousands of samples every year.
Rapid throughput, with the need for results to be reported the same day that samples are received, is critical for proper management of recreational and commercial shellfish resources for public health protection. Since samples are blind to the analyst, dilution levels for positive samples are 'trial and error' until the proper range is achieved to accurately determine the concentration of STX present. Therefore, quantification of a single sample could require multiple assays (i.e., multiple plates). To use the RBA efficiently for regulatory samples, a strategy for initial sample dilution is necessary. To A c c e p t e d M a n u s c r i p t concentration (e.g., for tracking potential bloom development) was of value to the shellfish program manager. We believe this would be the most efficient way to implement the RBA in a regulatory monitoring program. It is recommended that each lab conduct an evaluation of this approach to determine the appropriate screening dilutions to minimize the probability of 'false alarms', in which a screening result > 800 μg STX equiv. kg -1 was subsequently quantitated and determined to be < 800 μg STX equiv. kg -1 .
Rapid PSP Test Kits for Screening of Negative Samples and Early Detection
Of the qualitative test kits commercially available for PSP toxins testing, the Scotia® Rapid Test (SRT) from Scotia Rapid Testing® (Laycock et al. 2010 ) was approved for use as a screening method by the ISSC in 2005. This qualitative lateral flow immunochromatography test was developed based on antibodies against neosaxitoxin (NEO), with cross-reactivity evaluated for STX and several analogs (STX, GTX 2/3, NEO, and GTX ¼) (Burk et al. 1995) . The SRT-AOAC test uses the same AOAC extraction procedure as the MBA and thus one sample extraction can be used for both methods. As a result of its acceptance for screening, the CDPH-MDL has focused their attention on the evaluation of this test kit. Prior to the ISSC approval of SRT-AOAC, every shellfish sample received by CDPH-MDL was tested by MBA. Following the ISSC acceptance of the SRT-AOAC and its incorporation into the NSSP Model Ordinance, CDPH-MDL began using this presence/absence test to identify negative samples, with only the positive samples requiring quantitation by MBA. Because the majority of samples received are negative by MBA, CDPH-MDL reported a significant savings in animals and lab resources after this screening procedure was implemented (Oshiro et al. 2006) . Although SRT-AOAC has proven to be a reliable and useful method for this initial screening process, oftentimes samples positive by SRT-AOAC A c c e p t e d M a n u s c r i p t
Field testing for PSP
Although not approved for regulatory use, there is a test kit for PSP toxins from Scotia
Rapid Testing® designed for field use that utilizes a simpler and faster extraction method. This rapid extraction procedure is a mixture of 70% isopropyl alcohol (i.e., rubbing alcohol) and 5% acetic acid (i.e., vinegar) and uses the same test strip as the SRT-AOAC test. As a separate part of this project, three field sites were established for sampling of mussels and field testing with the Scotia® Rapid Extraction procedure 
Porcine Membrane Alternate
Early work on the binding properties of STX to voltage gated sodium channels was conducted on a variety of animal tissue models, including rabbit brain (Strichartz 1981a; Strichartz & Hansen Bay 1981b) , rat skeletal muscle (Barchi et al. 1980) , rat brain (Hartshorne et al. 1984) , and frog sciatic nerve (Strichartz 1984) . During studies with G. R. Strichartz on the pharmacology of purified saxitoxins using an RBA, Hall noted that the binding affinities correlated well with the potencies observed in the mouse assay. It was therefore evident that the receptor assay could be a useful alternative to the mouse assay. Although the RBA represented a dramatic reduction in the sacrifice of animals, it still depended on this practice for the supply of brain tissue. To explore the use of slaughterhouse byproduct instead of tissue from experimental animals, Hall prepared a suspension of bovine brain and demonstrated that it worked well (S. Hall, personal communication). In addition to the continued sacrifice of live animals, another impediment to the adoption of the RBA for regulatory use is the fact that, while the rat brains are commercially available, the prepared membrane homogenate is not. The preparation of this membrane and its standardization is a labour-intensive procedure in the laboratory. The rat membrane is also a very heterogeneous mixture and needs to be mixed (agitated) each time an aliquot is pipetted to a set of eight wells. One batch of homogenate prepared using 20 brains is adequate for 100 plates (or 700 samples using A c c e p t e d M a n u s c r i p t the plate layout in Figure 1) for use in the RBA. We performed initial testing of this porcine membrane for its use with the RBA (Figure 6 ). The porcine membrane was very homogenous and unlike the rat membrane didn't require continuous agitation. Overall, the porcine membrane reference values were lower ~ 700 cpm (counts per minute) compared to that of the rat membrane values of ~900 cpm, indicating possible lower binding capacity i.e., a lower number of receptor sites. This can be easily overcome by finding an optimum working dilution, by performing a protein assay of the membrane preparation (Van Dolah et al. 2013) . Reproducibility between wells was better with the porcine membrane than with the rat membrane, with RSDs of 12% and 18% respectively, probably due to the homogeneity of the former. These initial results are very promising and demonstrate the porcine membrane, which can be commercially obtained already standardized with high homogeneity, would be an excellent candidate for use with RBA in regulatory applications.
Conclusion
The receptor binding assay approved recently by ISSC for testing of mussel tissue for PSP toxins was further evaluated for its overall performance (accuracy, recovery, ruggedness, comparability) and for its use under regulatory conditions. The large number of samples analysed and the diversity of the tests conducted in this study demonstrates a robust set of quality assurance data to affirm the use of the RBA as an affordable rapid method for STX detection that is also free of the routine sacrifice of showed scatter in the relationship. Given the excellent recovery of spiked tissue by RBA, the variability must lie in the MBA results, which suffers from matrix effects and a lack of precision in determining death times.
The third study was conducted between three independent laboratories, two of which performed the RBA and one the MBA. A c c e p t e d M a n u s c r i p t general pattern of increasing variances of the triplicate spike recovery data with increasing spike concentration.
Lastly we explored ways to optimize the RBA under regulatory use, where laboratories test thousands of samples every year with rapid throughput of results.
Several ways of optimizing the assay for its efficient use are discussed, such as the use of an initial screening plate to separate those samples that exceed the alert level from the rest; using rapid PSP test kits in the field and in the laboratory for screening negative samples and early detection; and using an alternate commercially available Porcine membrane replacing the laboratory prepared rat membrane homogenate.
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